SNGX (STOCKS)
Soligenix, Inc. Common Stock
$1.132800
+0.012800 (+1.14%)
Prev close: $1.120000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Christopher J. Schaber
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $11.90M
- Employees
- 16
- P/E (TTM)
- -0.42
- P/B (TTM)
- 2.13
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $258.48K |
| Operating Expenses | $11.85M |
| Research and Development | $7.49M |
| Other Operating Expenses | $4.36M |
| Operating Income/Loss | -$11.85M |
| Income/Loss From Continuing Operations After Tax | -$11.08M |
| Income/Loss From Continuing Operations Before Tax | -$11.59M |
| Income Tax Expense/Benefit | -$506.62K |
| Net Income/Loss | -$11.08M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.08M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.08M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.14 |
| Diluted Earnings Per Share | -$2.14 |
| Basic Average Shares | 5,188,799 |
| Diluted Average Shares | 5,188,799 |
| Assets | $9.24M |
| Current Assets | $8.85M |
| Prepaid Expenses | $894.31K |
| Other Current Assets | $7.95M |
| Noncurrent Assets | $386.51K |
| Fixed Assets | $8.77K |
| Other Non-current Assets | $377.74K |
| Liabilities | $3.94M |
| Current Liabilities | $3.70M |
| Accounts Payable | $1.12M |
| Wages | $488.13K |
| Other Current Liabilities | $2.10M |
| Noncurrent Liabilities | $244.12K |
| Equity | $5.29M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.29M |
| Liabilities And Equity | $9.24M |
| Net Cash Flow From Operating Activities | -$10.27M |
| Net Cash Flow From Operating Activities, Continuing | -$10.27M |
| Net Cash Flow From Investing Activities | -$5.88K |
| Net Cash Flow From Investing Activities, Continuing | -$5.88K |
| Net Cash Flow From Financing Activities | $10.39M |
| Net Cash Flow From Financing Activities, Continuing | $10.39M |
| Net Cash Flow | $116.64K |
| Net Cash Flow, Continuing | $116.64K |
| Comprehensive Income/Loss | -$11.08M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.08M |
| Other Comprehensive Income/Loss | $0.00 |